Who to call at Pyxis Oncology, Inc., and when
Fundz watches for the moments Pyxis Oncology, Inc. starts buying, and tells you who to reach.
- An alert the day Pyxis Oncology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pyxis Oncology, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pyxis Oncology, Inc.. With Fundz connected, it knows.
Pyxis Oncology, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.pyxisoncology.comAI Executive Summary
AI-powered analysis of 8-K filing content
Pyxis Oncology completed an underwritten public offering on October 1, 2026, raising $150 million through the issuance of common stock and warrants. This capital infusion strengthens the company's financial position to advance its oncology research and development pipeline.
Key Takeaways
Pyxis raised $150 million through an underwritten public offering of 36.0 million common shares and 1.9 million pre-funded warrants, with an additional 49.3 million common warrants issued
The offering was underwritten by Leerink Partners, Guggenheim Securities, and Wells Fargo Securities, indicating strong institutional backing
2 more takeaways
Related Filings (2)
2 more filings from Pyxis Oncology, Inc. in the last 90 days
Filing Overview
What This Means
Pyxis Oncology, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.